AR039175A1 - Derivados de morfolina, antagonistas de ccr3 - Google Patents

Derivados de morfolina, antagonistas de ccr3

Info

Publication number
AR039175A1
AR039175A1 ARP030101088A ARP030101088A AR039175A1 AR 039175 A1 AR039175 A1 AR 039175A1 AR P030101088 A ARP030101088 A AR P030101088A AR P030101088 A ARP030101088 A AR P030101088A AR 039175 A1 AR039175 A1 AR 039175A1
Authority
AR
Argentina
Prior art keywords
morfolina
derivatives
substituted
ccr3 antagonists
alkyl
Prior art date
Application number
ARP030101088A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AR039175A1 publication Critical patent/AR039175A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Reivindicación 1: Un compuesto de fórmula (1) en la que: R1 representa heterociclilo sustituido o no sustituido; Y representa -(CRnaRnb)n-; Cada uno de Rna y Rnb es independientemente H o alquilo C1-6; n es un número entero de 1 a 5; R2 representa arilo sustituido o no sustituido o heteroarilo sustituido o no sustituido; R3 representa H o alquilo C1-6; y sales o solvatos de los mismos; con la condición de que se excluyan los siguientes compuestos: N-{[4-(3,4-diclorobencil)morfolin-2-il]metil}-2-(1,1-dioxidotiomorfolin-4-il)acetamida).
ARP030101088A 2002-03-28 2003-03-27 Derivados de morfolina, antagonistas de ccr3 AR039175A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0207445.8A GB0207445D0 (en) 2002-03-28 2002-03-28 Novel compounds

Publications (1)

Publication Number Publication Date
AR039175A1 true AR039175A1 (es) 2005-02-09

Family

ID=9933995

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101088A AR039175A1 (es) 2002-03-28 2003-03-27 Derivados de morfolina, antagonistas de ccr3

Country Status (7)

Country Link
EP (1) EP1495020A1 (es)
JP (1) JP2005529094A (es)
AR (1) AR039175A1 (es)
AU (1) AU2003215677A1 (es)
GB (1) GB0207445D0 (es)
TW (1) TW200403239A (es)
WO (1) WO2003082863A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1801108E (pt) 2004-09-08 2012-12-03 Mitsubishi Tanabe Pharma Corp Composto de morfolina para o tratamento de inflamações
EP1919884A1 (en) * 2005-07-21 2008-05-14 AstraZeneca AB N-benzyl-morpholine derivatives as modulators of the chemokine receptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19624668A1 (de) * 1996-06-20 1998-02-19 Klinge Co Chem Pharm Fab Verwendung von Pyridylalkan-, Pyridylalken- bzw. Pyridylalkinsäureamiden
IL125658A0 (en) * 1997-08-18 1999-04-11 Hoffmann La Roche Ccr-3 receptor antagonists
CA2423251A1 (en) * 2000-09-29 2002-04-04 Glaxo Group Limited Morpholin-acetamide derivatives for the treatment of inflammatory diseases

Also Published As

Publication number Publication date
WO2003082863A1 (en) 2003-10-09
EP1495020A1 (en) 2005-01-12
AU2003215677A1 (en) 2003-10-13
TW200403239A (en) 2004-03-01
JP2005529094A (ja) 2005-09-29
GB0207445D0 (en) 2002-05-08

Similar Documents

Publication Publication Date Title
PE20040155A1 (es) Derivados aminoinazoles, procedimiento de preparacion e intermedios de este procedimiento a titulo de medicamentos y composiciones farmaceuticas que los contienen
EA200600509A1 (ru) Соединения пиримидотиофена
DK1117297T3 (da) Syntetiske analoger af ecteinascidin-743
AR038536A1 (es) N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
EA200601235A1 (ru) Производные тиазола
HUP9802859A2 (hu) Acil-amino-szalicilsav-amid-származékok és alkalmazásuk peszticidként
CO5160347A1 (es) Derivados de acido carbamico
AR053405A1 (es) Derivados de urea sustituidas, composiciones farmaceuticas y metodos para el tratamiento de cardiopatias
AR055053A1 (es) Compuestos indol sustituidos con actividad inhibidora de nos. composiciones farmaceuticas.
HRP20040690B1 (en) Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
ATE152719T1 (de) Chinolylbenzofuran derivate als leukotrien- antagonisten
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
AR050435A1 (es) DERIVADOS DE HIDROXIAMIDA, PROCESOS DE OBTENCIoN Y COMPOSICIONES FARMACÉUTICAS.
KR920002555A (ko) 앤지오텐신 ii 수용체 길항질인 신규한 피리미딘 유도체, 그 제조방법 및 그를 포함하는 제약학적 조성물
AR039172A1 (es) Derivados de morfolina, antagonistas de ccr3.
AR044400A1 (es) Procesos para la preparacion de derivados de pirimidina
SE0101579D0 (sv) New compounds
EA200500717A1 (ru) Новые соединения имидазопиридина, способ их получения и фармацевтические композиции, которые их содержат
NO20082226L (no) 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav
ATE374750T1 (de) Serotoninwiederaufnahme-inhibitoren
WO2004046151A3 (en) Porphyrin derivatives
AR039175A1 (es) Derivados de morfolina, antagonistas de ccr3
DK1299388T3 (da) Variolin-derivater som anti-cancermidler
BR0013409B1 (pt) compostos fungicidas possuindo uma porção flúorvinil ou fluorpropenil-oxifeniloxima e processo para preparação dos mesmos.
AR039613A1 (es) Derivados de morfolina, antagonistas de ccr3.

Legal Events

Date Code Title Description
FB Suspension of granting procedure